Insta
India Introduces Stricter Measures For Exporting Cough Syrups After Child Deaths In Gambia, Uzbekistan
Swarajya News Staff
May 23, 2023, 05:17 PM | Updated 05:17 PM IST
Save & read from anywhere!
Bookmark stories for easy access on any device or the Swarajya app.
After Indian-made cough syrups were linked to child deaths in Gambia and Uzbekistan, India will only allow cough syrup exports after government laboratory testing, according to a notice on Tuesday (23 May).
Starting from 1 June, in order to be exported, all cough syrups need a certificate of analysis from a government laboratory.
Cough syrups made in India are said to have caused 70 child deaths in Gambia and 19 in Uzbekistan, harming the reputation of India's $41 billion pharmaceutical industry.
India may alter its pharmaceutical industry policy, with plans to enhance cough syrup and raw materials testing, according to a recent Reuters report.
India exported cough syrups worth $17.6 billion in 2022-23, as against $17 billion in 2021-22.
Save & read from anywhere!
Bookmark stories for easy access on any device or the Swarajya app.
Support Swarajya's 50 Ground Reports Project & Sponsor A Story
Every general election Swarajya does a 50 ground reports project.
Aimed only at serious readers and those who appreciate the nuances of political undercurrents, the project provides a sense of India's electoral landscape. As you know, these reports are produced after considerable investment of travel, time and effort on the ground.
This time too we've kicked off the project in style and have covered over 30 constituencies already. If you're someone who appreciates such work and have enjoyed our coverage please consider sponsoring a ground report for just Rs 2999 to Rs 19,999 - it goes a long way in helping us produce more quality reportage.
You can also back this project by becoming a subscriber for as little as Rs 999 - so do click on this links and choose a plan that suits you and back us.
Click below to contribute.